| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 326 | 2024 | 2165 | 39.360 |
Why?
|
| Lupus Nephritis | 43 | 2025 | 327 | 12.790 |
Why?
|
| T-Lymphocytes | 179 | 2022 | 10264 | 10.610 |
Why?
|
| Interleukin-2 | 70 | 2024 | 1895 | 9.740 |
Why?
|
| Interleukin-17 | 37 | 2024 | 924 | 8.230 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 19 | 2025 | 75 | 7.990 |
Why?
|
| Autoimmunity | 50 | 2024 | 1361 | 7.770 |
Why?
|
| Protein Phosphatase 2 | 22 | 2024 | 231 | 7.570 |
Why?
|
| Cyclic AMP Response Element Modulator | 31 | 2021 | 88 | 7.450 |
Why?
|
| Th17 Cells | 26 | 2024 | 791 | 5.900 |
Why?
|
| Reperfusion Injury | 35 | 2017 | 1039 | 5.210 |
Why?
|
| Podocytes | 10 | 2025 | 404 | 4.940 |
Why?
|
| T-Lymphocyte Subsets | 37 | 2024 | 1815 | 4.760 |
Why?
|
| T-Lymphocytes, Regulatory | 38 | 2024 | 3114 | 4.320 |
Why?
|
| Autoimmune Diseases | 47 | 2023 | 2256 | 4.160 |
Why?
|
| Receptors, Antigen, T-Cell | 57 | 2024 | 2568 | 3.950 |
Why?
|
| Lymphocyte Activation | 92 | 2021 | 5505 | 3.680 |
Why?
|
| B-Lymphocytes | 83 | 2023 | 4791 | 3.520 |
Why?
|
| Autoantibodies | 52 | 2023 | 2117 | 3.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 31 | 2024 | 4415 | 3.490 |
Why?
|
| Mice, Inbred MRL lpr | 35 | 2024 | 158 | 3.460 |
Why?
|
| Complement System Proteins | 18 | 2022 | 738 | 3.180 |
Why?
|
| Complement Activation | 25 | 2022 | 447 | 3.100 |
Why?
|
| Animals | 259 | 2025 | 169222 | 2.310 |
Why?
|
| Receptors, Complement | 22 | 2015 | 254 | 2.260 |
Why?
|
| Signal Transduction | 88 | 2024 | 23642 | 2.260 |
Why?
|
| Gene Expression Regulation | 53 | 2021 | 11930 | 2.230 |
Why?
|
| Interleukin-23 | 8 | 2024 | 202 | 2.230 |
Why?
|
| Membrane Proteins | 32 | 2024 | 7876 | 2.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 21 | 2022 | 4648 | 2.130 |
Why?
|
| Mice | 162 | 2025 | 82024 | 2.090 |
Why?
|
| Glutaminase | 3 | 2022 | 31 | 2.060 |
Why?
|
| Protein-Tyrosine Kinases | 19 | 2015 | 2428 | 2.030 |
Why?
|
| Promoter Regions, Genetic | 38 | 2021 | 5798 | 2.000 |
Why?
|
| Cytokines | 38 | 2023 | 7450 | 1.990 |
Why?
|
| Lupus Erythematosus, Cutaneous | 5 | 2021 | 75 | 1.970 |
Why?
|
| Lymphocytes | 33 | 2022 | 2614 | 1.960 |
Why?
|
| Calcium | 43 | 2024 | 5794 | 1.910 |
Why?
|
| Down-Regulation | 30 | 2018 | 2936 | 1.900 |
Why?
|
| Kidney | 22 | 2024 | 7065 | 1.840 |
Why?
|
| Calcium Signaling | 12 | 2021 | 739 | 1.820 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 16 | 2015 | 2889 | 1.700 |
Why?
|
| Response Elements | 8 | 2018 | 308 | 1.680 |
Why?
|
| Humans | 522 | 2024 | 767991 | 1.620 |
Why?
|
| Epigenesis, Genetic | 16 | 2019 | 3834 | 1.620 |
Why?
|
| Mesangial Cells | 3 | 2018 | 23 | 1.610 |
Why?
|
| Shock, Hemorrhagic | 7 | 2016 | 224 | 1.610 |
Why?
|
| Benzylamines | 4 | 2019 | 251 | 1.560 |
Why?
|
| Up-Regulation | 27 | 2024 | 4146 | 1.540 |
Why?
|
| Cell Differentiation | 30 | 2024 | 11665 | 1.520 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 14 | 2024 | 977 | 1.510 |
Why?
|
| ADAM Proteins | 2 | 2024 | 242 | 1.490 |
Why?
|
| Autoantigens | 16 | 2022 | 890 | 1.490 |
Why?
|
| Receptors, Complement 3d | 17 | 2013 | 117 | 1.460 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2019 | 336 | 1.460 |
Why?
|
| Intestines | 16 | 2012 | 1909 | 1.430 |
Why?
|
| Th1 Cells | 4 | 2021 | 1042 | 1.400 |
Why?
|
| Complement C3d | 8 | 2012 | 21 | 1.390 |
Why?
|
| Immunoglobulin G | 29 | 2024 | 4564 | 1.380 |
Why?
|
| Skin | 11 | 2024 | 4503 | 1.370 |
Why?
|
| Antibodies, Antinuclear | 13 | 2022 | 342 | 1.370 |
Why?
|
| Mice, Knockout | 46 | 2025 | 14486 | 1.340 |
Why?
|
| Inflammation | 27 | 2024 | 10871 | 1.320 |
Why?
|
| Transcriptional Activation | 9 | 2017 | 1752 | 1.320 |
Why?
|
| Complement Pathway, Alternative | 7 | 2021 | 113 | 1.310 |
Why?
|
| Jurkat Cells | 21 | 2024 | 740 | 1.310 |
Why?
|
| Interferon-gamma | 19 | 2024 | 3159 | 1.300 |
Why?
|
| HSP70 Heat-Shock Proteins | 14 | 2006 | 394 | 1.300 |
Why?
|
| DNA Methylation | 17 | 2019 | 4426 | 1.280 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2024 | 638 | 1.270 |
Why?
|
| Membrane Microdomains | 9 | 2014 | 205 | 1.260 |
Why?
|
| Complement C3 | 19 | 2020 | 434 | 1.230 |
Why?
|
| Repressor Proteins | 11 | 2018 | 2982 | 1.230 |
Why?
|
| Antigens, CD | 14 | 2016 | 4035 | 1.210 |
Why?
|
| NAD | 2 | 2024 | 618 | 1.190 |
Why?
|
| Phosphorylation | 40 | 2021 | 8314 | 1.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 6 | 2019 | 822 | 1.130 |
Why?
|
| Oxazines | 4 | 2015 | 358 | 1.130 |
Why?
|
| Receptors, Interleukin-2 | 13 | 2019 | 564 | 1.110 |
Why?
|
| Mice, Inbred C57BL | 53 | 2025 | 22381 | 1.110 |
Why?
|
| Receptors, IgG | 13 | 2017 | 564 | 1.050 |
Why?
|
| Self Tolerance | 2 | 2018 | 122 | 1.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2018 | 1168 | 1.030 |
Why?
|
| Sulfonamides | 6 | 2019 | 1982 | 1.030 |
Why?
|
| Chromatin Assembly and Disassembly | 7 | 2018 | 633 | 1.020 |
Why?
|
| Dendritic Cells | 11 | 2021 | 2745 | 1.020 |
Why?
|
| Immune Tolerance | 16 | 2022 | 2322 | 1.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 5 | 2012 | 67 | 1.000 |
Why?
|
| Gene Expression | 24 | 2016 | 7597 | 1.000 |
Why?
|
| Blood Platelets | 7 | 2023 | 2479 | 1.000 |
Why?
|
| Rheumatic Diseases | 9 | 2021 | 659 | 0.990 |
Why?
|
| Plasma Cells | 2 | 2019 | 599 | 0.980 |
Why?
|
| Intestine, Small | 6 | 2017 | 1216 | 0.970 |
Why?
|
| Splanchnic Circulation | 7 | 2012 | 122 | 0.970 |
Why?
|
| Mesentery | 7 | 2012 | 202 | 0.970 |
Why?
|
| Arthritis, Rheumatoid | 23 | 2021 | 3781 | 0.950 |
Why?
|
| Epithelial Cells | 7 | 2024 | 3703 | 0.930 |
Why?
|
| RNA, Messenger | 33 | 2024 | 12797 | 0.930 |
Why?
|
| Lymphopoiesis | 3 | 2020 | 133 | 0.930 |
Why?
|
| DNA-Binding Proteins | 31 | 2018 | 9614 | 0.920 |
Why?
|
| MicroRNAs | 8 | 2017 | 3804 | 0.920 |
Why?
|
| Antigen-Antibody Complex | 11 | 2025 | 513 | 0.900 |
Why?
|
| Immunoglobulin M | 19 | 2015 | 1527 | 0.890 |
Why?
|
| Kidney Tubules | 3 | 2024 | 454 | 0.880 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 3 | 2017 | 151 | 0.880 |
Why?
|
| Cells, Cultured | 45 | 2021 | 19017 | 0.860 |
Why?
|
| Antigen-Presenting Cells | 11 | 2017 | 960 | 0.860 |
Why?
|
| Transcription, Genetic | 30 | 2013 | 7612 | 0.860 |
Why?
|
| Phosphofructokinases | 1 | 2022 | 6 | 0.850 |
Why?
|
| Antiphospholipid Syndrome | 2 | 2019 | 166 | 0.840 |
Why?
|
| Lung | 16 | 2021 | 10094 | 0.840 |
Why?
|
| Enzyme Inhibitors | 17 | 2019 | 3726 | 0.830 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 20 | 2016 | 4576 | 0.820 |
Why?
|
| CD40 Ligand | 5 | 2022 | 528 | 0.820 |
Why?
|
| Complement C4b | 5 | 2016 | 124 | 0.820 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2018 | 327 | 0.800 |
Why?
|
| Histones | 16 | 2024 | 2600 | 0.800 |
Why?
|
| Receptors, Cell Surface | 8 | 2024 | 2819 | 0.790 |
Why?
|
| Cyclic AMP | 7 | 2021 | 1471 | 0.790 |
Why?
|
| NF-kappa B | 12 | 2024 | 2493 | 0.780 |
Why?
|
| T-Lymphocytes, Cytotoxic | 6 | 2020 | 1801 | 0.780 |
Why?
|
| Sirtuin 2 | 1 | 2022 | 93 | 0.780 |
Why?
|
| Flow Cytometry | 21 | 2020 | 5902 | 0.770 |
Why?
|
| Skin Diseases | 4 | 2021 | 1084 | 0.760 |
Why?
|
| Glomerulonephritis | 8 | 2017 | 333 | 0.750 |
Why?
|
| Caspase 3 | 7 | 2016 | 730 | 0.750 |
Why?
|
| Female | 164 | 2025 | 397113 | 0.750 |
Why?
|
| Immunity, Cellular | 11 | 2021 | 1561 | 0.740 |
Why?
|
| Kidney Glomerulus | 3 | 2018 | 571 | 0.740 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2019 | 5694 | 0.740 |
Why?
|
| Alternative Splicing | 8 | 2015 | 1104 | 0.730 |
Why?
|
| Amino Acid Transport Systems | 1 | 2021 | 34 | 0.730 |
Why?
|
| Antibodies, Monoclonal | 30 | 2021 | 9252 | 0.730 |
Why?
|
| Receptors, Interleukin | 5 | 2021 | 243 | 0.730 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2021 | 99 | 0.730 |
Why?
|
| Disease Models, Animal | 39 | 2020 | 18344 | 0.730 |
Why?
|
| Transcription Factors | 27 | 2020 | 12165 | 0.720 |
Why?
|
| Wounds and Injuries | 5 | 2020 | 2515 | 0.720 |
Why?
|
| Cell Membrane | 10 | 2024 | 3657 | 0.720 |
Why?
|
| Erythrocytes | 7 | 2020 | 2418 | 0.710 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 6 | 2020 | 812 | 0.710 |
Why?
|
| Arthritis, Experimental | 1 | 2023 | 293 | 0.710 |
Why?
|
| RNA-Binding Proteins | 5 | 2024 | 1889 | 0.700 |
Why?
|
| Rheumatology | 3 | 2021 | 617 | 0.700 |
Why?
|
| Immune System | 5 | 2020 | 799 | 0.700 |
Why?
|
| Disease Susceptibility | 5 | 2020 | 1793 | 0.700 |
Why?
|
| Complement C5a | 5 | 2012 | 100 | 0.690 |
Why?
|
| Scleroderma, Systemic | 7 | 2015 | 346 | 0.690 |
Why?
|
| Complement Inactivating Agents | 3 | 2021 | 53 | 0.680 |
Why?
|
| 3' Untranslated Regions | 6 | 2015 | 515 | 0.680 |
Why?
|
| Ribonucleoproteins | 4 | 2007 | 359 | 0.680 |
Why?
|
| Nuclear Proteins | 11 | 2014 | 5799 | 0.670 |
Why?
|
| Leukocytes, Mononuclear | 9 | 2019 | 1854 | 0.670 |
Why?
|
| Arthritis | 4 | 2021 | 684 | 0.670 |
Why?
|
| Immunotherapy | 6 | 2022 | 4748 | 0.670 |
Why?
|
| Nitric Oxide Synthase | 7 | 2004 | 911 | 0.670 |
Why?
|
| Enteritis | 3 | 2011 | 164 | 0.660 |
Why?
|
| Receptors, Complement 3b | 12 | 2015 | 136 | 0.650 |
Why?
|
| Killer Cells, Natural | 9 | 2021 | 2211 | 0.650 |
Why?
|
| Protein Binding | 23 | 2019 | 9343 | 0.650 |
Why?
|
| Thiadiazoles | 1 | 2019 | 63 | 0.650 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2010 | 257 | 0.650 |
Why?
|
| Aspartic Acid | 1 | 2021 | 577 | 0.650 |
Why?
|
| Toll-Like Receptors | 6 | 2020 | 582 | 0.650 |
Why?
|
| Viruses | 1 | 2023 | 373 | 0.640 |
Why?
|
| Receptors, Fc | 8 | 2016 | 537 | 0.640 |
Why?
|
| Joints | 1 | 2021 | 324 | 0.640 |
Why?
|
| Protein Kinase C | 13 | 2002 | 1207 | 0.640 |
Why?
|
| Genetic Predisposition to Disease | 25 | 2024 | 18062 | 0.640 |
Why?
|
| Male | 145 | 2024 | 364641 | 0.630 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 6 | 2009 | 500 | 0.630 |
Why?
|
| Resuscitation | 4 | 2016 | 679 | 0.630 |
Why?
|
| Blotting, Western | 17 | 2017 | 5024 | 0.630 |
Why?
|
| Peptide Fragments | 7 | 2016 | 5151 | 0.630 |
Why?
|
| Sulfides | 1 | 2019 | 171 | 0.620 |
Why?
|
| Mesenteric Arteries | 2 | 2012 | 178 | 0.620 |
Why?
|
| Nanoconjugates | 1 | 2018 | 22 | 0.620 |
Why?
|
| Glycolysis | 2 | 2019 | 837 | 0.620 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 247 | 0.610 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2020 | 3813 | 0.600 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2007 | 514 | 0.600 |
Why?
|
| Receptors, Antigen, B-Cell | 12 | 2015 | 547 | 0.600 |
Why?
|
| Tyrosine | 11 | 2016 | 1427 | 0.590 |
Why?
|
| Fibrosis | 2 | 2024 | 2080 | 0.590 |
Why?
|
| Takayasu Arteritis | 1 | 2019 | 106 | 0.590 |
Why?
|
| Homeodomain Proteins | 4 | 2021 | 2429 | 0.590 |
Why?
|
| Ikaros Transcription Factor | 2 | 2022 | 233 | 0.590 |
Why?
|
| Pyridines | 4 | 2015 | 2893 | 0.570 |
Why?
|
| Gene Expression Profiling | 6 | 2017 | 9536 | 0.570 |
Why?
|
| rho-Associated Kinases | 6 | 2021 | 290 | 0.570 |
Why?
|
| Hemorrhage | 6 | 2016 | 3467 | 0.570 |
Why?
|
| Adult | 111 | 2024 | 223583 | 0.570 |
Why?
|
| Immunity, Innate | 10 | 2023 | 3079 | 0.570 |
Why?
|
| Antirheumatic Agents | 5 | 2021 | 1381 | 0.570 |
Why?
|
| Intestinal Mucosa | 14 | 2012 | 3044 | 0.560 |
Why?
|
| Complement C5 | 5 | 2006 | 104 | 0.560 |
Why?
|
| Complement C3a | 2 | 2016 | 66 | 0.560 |
Why?
|
| Case-Control Studies | 20 | 2020 | 22287 | 0.560 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2009 | 72 | 0.560 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2020 | 492 | 0.550 |
Why?
|
| Spleen | 10 | 2019 | 2295 | 0.550 |
Why?
|
| Immunophenotyping | 6 | 2016 | 1863 | 0.550 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 874 | 0.550 |
Why?
|
| Immunosuppressive Agents | 12 | 2020 | 4205 | 0.550 |
Why?
|
| Allergy and Immunology | 2 | 2010 | 170 | 0.540 |
Why?
|
| Azacitidine | 1 | 2018 | 336 | 0.540 |
Why?
|
| Mucin-1 | 1 | 2021 | 537 | 0.540 |
Why?
|
| Thyroid Hormones | 2 | 2019 | 408 | 0.540 |
Why?
|
| Neutrophil Infiltration | 9 | 2017 | 393 | 0.540 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2024 | 86 | 0.530 |
Why?
|
| Chromatin | 6 | 2019 | 2981 | 0.530 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 64 | 0.530 |
Why?
|
| Middle Aged | 89 | 2024 | 223422 | 0.530 |
Why?
|
| Lung Injury | 1 | 2021 | 433 | 0.520 |
Why?
|
| Transfection | 20 | 2014 | 5757 | 0.520 |
Why?
|
| Receptors, CCR6 | 1 | 2016 | 73 | 0.520 |
Why?
|
| Caspases | 5 | 2010 | 882 | 0.520 |
Why?
|
| Virus Diseases | 1 | 2022 | 723 | 0.520 |
Why?
|
| Cytosol | 8 | 2011 | 887 | 0.520 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 484 | 0.510 |
Why?
|
| Complement C1 Inhibitor Protein | 2 | 2016 | 97 | 0.510 |
Why?
|
| Transcription Factor AP-1 | 6 | 2011 | 322 | 0.510 |
Why?
|
| Osteogenesis | 1 | 2023 | 1288 | 0.510 |
Why?
|
| Arthritis, Psoriatic | 4 | 2024 | 219 | 0.510 |
Why?
|
| Cell Proliferation | 11 | 2022 | 10470 | 0.510 |
Why?
|
| Complement C3-C5 Convertases | 10 | 1993 | 30 | 0.510 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 11 | 2004 | 482 | 0.500 |
Why?
|
| RNA Stability | 2 | 2008 | 319 | 0.490 |
Why?
|
| Platelet Activation | 3 | 2023 | 644 | 0.490 |
Why?
|
| Polyethyleneimine | 1 | 2015 | 68 | 0.490 |
Why?
|
| Nitric Oxide | 7 | 2020 | 2146 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2011 | 582 | 0.490 |
Why?
|
| Gene Silencing | 5 | 2018 | 1505 | 0.490 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2016 | 527 | 0.490 |
Why?
|
| Cell Adhesion Molecules | 8 | 2012 | 1613 | 0.490 |
Why?
|
| Quinones | 2 | 2006 | 79 | 0.490 |
Why?
|
| Neutrophils | 12 | 2024 | 3786 | 0.480 |
Why?
|
| Apoptosis | 20 | 2016 | 9521 | 0.480 |
Why?
|
| Interleukin-10 | 3 | 2014 | 1183 | 0.480 |
Why?
|
| Interleukin-4 | 5 | 2017 | 1156 | 0.480 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2014 | 19 | 0.480 |
Why?
|
| Immunoblotting | 8 | 2016 | 1647 | 0.480 |
Why?
|
| Antibodies | 8 | 2012 | 2421 | 0.480 |
Why?
|
| Transcription Factor RelA | 6 | 2006 | 252 | 0.480 |
Why?
|
| Acetylation | 6 | 2014 | 1055 | 0.470 |
Why?
|
| Amino Acids | 1 | 2021 | 1716 | 0.470 |
Why?
|
| Single-Chain Antibodies | 1 | 2015 | 114 | 0.460 |
Why?
|
| Cell Line | 32 | 2021 | 15597 | 0.460 |
Why?
|
| Antioxidants | 1 | 2022 | 1674 | 0.450 |
Why?
|
| Complement C3 Nephritic Factor | 8 | 1993 | 13 | 0.450 |
Why?
|
| Isoenzymes | 8 | 2021 | 1688 | 0.440 |
Why?
|
| Base Sequence | 17 | 2014 | 12418 | 0.440 |
Why?
|
| CpG Islands | 4 | 2012 | 1206 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2018 | 1244 | 0.440 |
Why?
|
| Intracellular Space | 1 | 2014 | 199 | 0.440 |
Why?
|
| Sp1 Transcription Factor | 2 | 2012 | 143 | 0.440 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 339 | 0.440 |
Why?
|
| Interleukins | 7 | 2021 | 796 | 0.430 |
Why?
|
| Toxoplasma | 1 | 2014 | 159 | 0.430 |
Why?
|
| Heat-Shock Proteins | 6 | 2000 | 797 | 0.430 |
Why?
|
| Monocytes | 14 | 2017 | 2605 | 0.430 |
Why?
|
| Forkhead Transcription Factors | 5 | 2024 | 1625 | 0.420 |
Why?
|
| Antigens, Viral | 2 | 2017 | 995 | 0.420 |
Why?
|
| Adaptive Immunity | 4 | 2014 | 733 | 0.420 |
Why?
|
| Chromatin Immunoprecipitation | 5 | 2015 | 858 | 0.420 |
Why?
|
| CREB-Binding Protein | 4 | 2009 | 147 | 0.420 |
Why?
|
| Methylprednisolone | 3 | 2013 | 386 | 0.420 |
Why?
|
| Thrombospondins | 1 | 2013 | 196 | 0.410 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 2 | 2006 | 71 | 0.410 |
Why?
|
| Receptors, Immunologic | 3 | 2016 | 1418 | 0.410 |
Why?
|
| Interferon Type I | 7 | 2020 | 569 | 0.410 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2013 | 42 | 0.410 |
Why?
|
| Complement Membrane Attack Complex | 3 | 2020 | 105 | 0.410 |
Why?
|
| Nephritis | 3 | 2011 | 146 | 0.410 |
Why?
|
| Receptors, IgE | 5 | 2003 | 375 | 0.410 |
Why?
|
| Antigens, Protozoan | 1 | 2014 | 315 | 0.400 |
Why?
|
| Cell Movement | 6 | 2011 | 5209 | 0.400 |
Why?
|
| Antibodies, Anti-Idiotypic | 9 | 2013 | 347 | 0.400 |
Why?
|
| Estrogens | 4 | 2012 | 1536 | 0.400 |
Why?
|
| Immunologic Memory | 6 | 2020 | 1377 | 0.390 |
Why?
|
| Antibodies, Bispecific | 1 | 2015 | 204 | 0.390 |
Why?
|
| Platelet Factor 4 | 1 | 2012 | 132 | 0.390 |
Why?
|
| Phospholipase C gamma | 4 | 2024 | 131 | 0.390 |
Why?
|
| RNA Splice Sites | 1 | 2013 | 213 | 0.390 |
Why?
|
| Benzoquinones | 3 | 2007 | 198 | 0.390 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2011 | 549 | 0.390 |
Why?
|
| NFATC Transcription Factors | 3 | 2012 | 393 | 0.390 |
Why?
|
| Kidney Diseases | 4 | 2023 | 2100 | 0.390 |
Why?
|
| Molecular Sequence Data | 19 | 2012 | 17617 | 0.380 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 483 | 0.380 |
Why?
|
| Biological Products | 1 | 2021 | 948 | 0.370 |
Why?
|
| Introns | 1 | 2014 | 966 | 0.370 |
Why?
|
| Pulmonary Fibrosis | 1 | 2015 | 506 | 0.370 |
Why?
|
| Organ Specificity | 4 | 2021 | 1968 | 0.370 |
Why?
|
| Hot Temperature | 9 | 2002 | 1441 | 0.360 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2007 | 240 | 0.360 |
Why?
|
| Emergency Medical Services | 1 | 2022 | 1947 | 0.360 |
Why?
|
| Immunohistochemistry | 12 | 2021 | 11068 | 0.360 |
Why?
|
| Membrane Glycoproteins | 7 | 2024 | 3710 | 0.360 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 610 | 0.360 |
Why?
|
| Trans-Activators | 8 | 2004 | 2857 | 0.360 |
Why?
|
| Sjogren's Syndrome | 5 | 2005 | 240 | 0.360 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.360 |
Why?
|
| Lactams, Macrocyclic | 3 | 2007 | 319 | 0.350 |
Why?
|
| Cholera Toxin | 3 | 2008 | 562 | 0.350 |
Why?
|
| Mesenteric Artery, Superior | 2 | 2017 | 96 | 0.350 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2009 | 3740 | 0.350 |
Why?
|
| Fluorescent Antibody Technique | 11 | 2016 | 2473 | 0.350 |
Why?
|
| Adipocytes | 1 | 2017 | 1197 | 0.350 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2019 | 2061 | 0.350 |
Why?
|
| Glucocorticoids | 4 | 2020 | 2166 | 0.350 |
Why?
|
| Aged | 51 | 2021 | 171446 | 0.350 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 627 | 0.350 |
Why?
|
| Protozoan Proteins | 2 | 2007 | 843 | 0.340 |
Why?
|
| Binding Sites | 12 | 2014 | 6022 | 0.340 |
Why?
|
| Receptors, CXCR5 | 2 | 2013 | 88 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2020 | 2456 | 0.340 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2019 | 306 | 0.340 |
Why?
|
| Mice, Transgenic | 10 | 2020 | 9556 | 0.340 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 1196 | 0.340 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2908 | 0.330 |
Why?
|
| Adjuvants, Immunologic | 6 | 2007 | 998 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 2496 | 0.330 |
Why?
|
| Keratinocytes | 3 | 2024 | 876 | 0.330 |
Why?
|
| Isotonic Solutions | 3 | 2016 | 119 | 0.330 |
Why?
|
| Jejunum | 2 | 2008 | 475 | 0.330 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 518 | 0.330 |
Why?
|
| Lymphocyte Subsets | 5 | 2020 | 313 | 0.330 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2011 | 587 | 0.330 |
Why?
|
| Lymph Nodes | 5 | 2022 | 3472 | 0.330 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 1361 | 0.330 |
Why?
|
| Lymphoid Tissue | 4 | 2020 | 445 | 0.320 |
Why?
|
| Complement C3b | 7 | 2015 | 98 | 0.320 |
Why?
|
| Plasmodium berghei | 2 | 2007 | 161 | 0.320 |
Why?
|
| Chemokine CXCL13 | 1 | 2009 | 62 | 0.320 |
Why?
|
| Hyperkalemia | 1 | 2011 | 233 | 0.320 |
Why?
|
| Morpholines | 4 | 2015 | 584 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2007 | 313 | 0.310 |
Why?
|
| Herpesvirus 4, Human | 15 | 2013 | 1082 | 0.310 |
Why?
|
| Biological Therapy | 1 | 2010 | 140 | 0.310 |
Why?
|
| Type C Phospholipases | 3 | 2001 | 287 | 0.310 |
Why?
|
| Antibody Formation | 10 | 2007 | 1392 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 6 | 2020 | 2824 | 0.310 |
Why?
|
| Fluid Therapy | 3 | 2016 | 587 | 0.310 |
Why?
|
| Cytotoxicity, Immunologic | 9 | 2019 | 1353 | 0.300 |
Why?
|
| Reactive Oxygen Species | 5 | 2023 | 2149 | 0.300 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2021 | 4351 | 0.300 |
Why?
|
| Genes, Reporter | 7 | 2015 | 1526 | 0.300 |
Why?
|
| Aminopyridines | 4 | 2015 | 580 | 0.300 |
Why?
|
| STAT5 Transcription Factor | 3 | 2019 | 268 | 0.300 |
Why?
|
| Prodrugs | 1 | 2010 | 274 | 0.300 |
Why?
|
| Molecular Biology | 1 | 2012 | 573 | 0.300 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 5 | 2002 | 110 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3798 | 0.300 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 7 | 1993 | 41 | 0.290 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 581 | 0.290 |
Why?
|
| Apoptosomes | 1 | 2007 | 4 | 0.290 |
Why?
|
| Ischemia | 5 | 2009 | 1900 | 0.290 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2019 | 4525 | 0.290 |
Why?
|
| Models, Immunological | 5 | 2014 | 518 | 0.290 |
Why?
|
| Heat-Shock Response | 2 | 2000 | 179 | 0.290 |
Why?
|
| Complement Inactivator Proteins | 4 | 2001 | 74 | 0.290 |
Why?
|
| Solubility | 10 | 2007 | 1083 | 0.290 |
Why?
|
| Thrombosis | 3 | 2023 | 2957 | 0.290 |
Why?
|
| Metagenome | 1 | 2011 | 465 | 0.290 |
Why?
|
| Inflammation Mediators | 4 | 2016 | 1892 | 0.280 |
Why?
|
| Androstenediol | 1 | 2006 | 3 | 0.280 |
Why?
|
| Mice, Inbred BALB C | 12 | 2022 | 6231 | 0.280 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2009 | 287 | 0.280 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2012 | 294 | 0.280 |
Why?
|
| Hypotension, Controlled | 1 | 2006 | 16 | 0.280 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 2 | 2017 | 32 | 0.280 |
Why?
|
| Nanoparticles | 1 | 2019 | 1983 | 0.280 |
Why?
|
| Carrier Proteins | 2 | 2019 | 4937 | 0.280 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 4427 | 0.270 |
Why?
|
| Cell Transformation, Viral | 9 | 1991 | 530 | 0.270 |
Why?
|
| Interferons | 4 | 2018 | 720 | 0.270 |
Why?
|
| Young Adult | 16 | 2021 | 60048 | 0.270 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2006 | 36 | 0.270 |
Why?
|
| Malaria | 2 | 2007 | 1249 | 0.260 |
Why?
|
| Neoplasms | 7 | 2022 | 22365 | 0.260 |
Why?
|
| Interferon-alpha | 4 | 2021 | 910 | 0.260 |
Why?
|
| Perforin | 2 | 2017 | 167 | 0.260 |
Why?
|
| Ephrin-A2 | 2 | 2002 | 25 | 0.260 |
Why?
|
| Integrin alpha4 | 2 | 2003 | 88 | 0.260 |
Why?
|
| Antigens, Surface | 5 | 2008 | 1617 | 0.260 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2007 | 289 | 0.260 |
Why?
|
| RNA, Small Interfering | 6 | 2016 | 3428 | 0.260 |
Why?
|
| Models, Animal | 6 | 2012 | 2120 | 0.260 |
Why?
|
| Nitroarginine | 2 | 2003 | 66 | 0.260 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2006 | 64 | 0.250 |
Why?
|
| Glutamine | 2 | 2019 | 577 | 0.250 |
Why?
|
| Tetradecanoylphorbol Acetate | 8 | 2013 | 826 | 0.250 |
Why?
|
| Enzyme Activation | 8 | 2014 | 3587 | 0.250 |
Why?
|
| Recombinant Proteins | 9 | 2012 | 6515 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2015 | 10757 | 0.250 |
Why?
|
| Chemokines | 2 | 2007 | 963 | 0.250 |
Why?
|
| Mitochondria | 4 | 2022 | 3681 | 0.250 |
Why?
|
| DNA | 12 | 2011 | 7213 | 0.250 |
Why?
|
| Aging | 1 | 2024 | 8744 | 0.240 |
Why?
|
| Adenosine Triphosphate | 3 | 2006 | 2004 | 0.240 |
Why?
|
| Dexamethasone | 5 | 2001 | 1964 | 0.240 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 4261 | 0.240 |
Why?
|
| Immunoglobulin Idiotypes | 4 | 1992 | 200 | 0.240 |
Why?
|
| Platelet Transfusion | 3 | 2012 | 301 | 0.240 |
Why?
|
| Lysine | 2 | 2014 | 1000 | 0.240 |
Why?
|
| Granzymes | 2 | 2017 | 277 | 0.240 |
Why?
|
| Immunoglobulins | 6 | 2012 | 854 | 0.240 |
Why?
|
| Egtazic Acid | 2 | 2002 | 166 | 0.240 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 688 | 0.240 |
Why?
|
| Dermatitis, Photoallergic | 1 | 2004 | 3 | 0.240 |
Why?
|
| Penicillamine | 2 | 2003 | 60 | 0.230 |
Why?
|
| Phenotype | 11 | 2024 | 16723 | 0.230 |
Why?
|
| Pityriasis Rubra Pilaris | 1 | 2024 | 20 | 0.230 |
Why?
|
| Fatigue Syndrome, Chronic | 2 | 2022 | 217 | 0.230 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 80 | 0.230 |
Why?
|
| Sodium Cyanide | 1 | 2003 | 9 | 0.230 |
Why?
|
| Immunity | 1 | 2010 | 1003 | 0.230 |
Why?
|
| Drug Delivery Systems | 3 | 2023 | 2230 | 0.230 |
Why?
|
| Liver | 2 | 2012 | 7574 | 0.230 |
Why?
|
| Abortion, Spontaneous | 1 | 2009 | 534 | 0.230 |
Why?
|
| Connective Tissue Diseases | 2 | 2006 | 285 | 0.220 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 4248 | 0.220 |
Why?
|
| Thapsigargin | 6 | 2001 | 102 | 0.220 |
Why?
|
| Antigens, CD20 | 2 | 2004 | 199 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 4 | 2019 | 1605 | 0.220 |
Why?
|
| Cell Nucleus | 9 | 2005 | 2881 | 0.220 |
Why?
|
| Proteinuria | 2 | 2018 | 612 | 0.220 |
Why?
|
| Ionomycin | 5 | 2013 | 110 | 0.220 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.220 |
Why?
|
| Complement C1 Inactivator Proteins | 1 | 2003 | 89 | 0.220 |
Why?
|
| Melanoma | 1 | 2022 | 5706 | 0.220 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2003 | 693 | 0.220 |
Why?
|
| HSP90 Heat-Shock Proteins | 3 | 2004 | 422 | 0.220 |
Why?
|
| Protein Isoforms | 5 | 2013 | 1715 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 186 | 0.220 |
Why?
|
| Amiloride | 1 | 2003 | 116 | 0.220 |
Why?
|
| Luciferases | 4 | 2015 | 714 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 16041 | 0.220 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 388 | 0.220 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2003 | 90 | 0.210 |
Why?
|
| Hemolytic Plaque Technique | 10 | 1987 | 59 | 0.210 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3669 | 0.210 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2003 | 462 | 0.210 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3228 | 0.210 |
Why?
|
| Systems Biology | 1 | 2006 | 482 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 4 | 2021 | 1996 | 0.210 |
Why?
|
| Lymphocyte Culture Test, Mixed | 14 | 2017 | 510 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.210 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2010 | 1621 | 0.210 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2024 | 299 | 0.210 |
Why?
|
| Catalytic Domain | 3 | 2018 | 699 | 0.210 |
Why?
|
| Plasmapheresis | 4 | 1985 | 206 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.200 |
Why?
|
| Cell Line, Transformed | 4 | 2018 | 866 | 0.200 |
Why?
|
| Cell Death | 4 | 2011 | 1679 | 0.200 |
Why?
|
| Actins | 3 | 2024 | 2064 | 0.200 |
Why?
|
| Protein Subunits | 5 | 2012 | 943 | 0.200 |
Why?
|
| Complement Activating Enzymes | 3 | 1990 | 22 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2001 | 354 | 0.200 |
Why?
|
| Multiple Sclerosis | 3 | 2014 | 3250 | 0.200 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 717 | 0.200 |
Why?
|
| Heat Stress Disorders | 2 | 2003 | 80 | 0.200 |
Why?
|
| Niacinamide | 1 | 2024 | 418 | 0.200 |
Why?
|
| Dermatitis | 1 | 2024 | 203 | 0.190 |
Why?
|
| Spondylitis, Ankylosing | 2 | 2015 | 159 | 0.190 |
Why?
|
| Kinetics | 14 | 2004 | 6328 | 0.190 |
Why?
|
| Coculture Techniques | 2 | 2019 | 1340 | 0.190 |
Why?
|
| Thymus Gland | 3 | 2024 | 1266 | 0.190 |
Why?
|
| Proto-Oncogenes | 4 | 1990 | 321 | 0.190 |
Why?
|
| Hypersensitivity | 1 | 2010 | 1168 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3771 | 0.190 |
Why?
|
| Molecular Weight | 7 | 2002 | 2173 | 0.190 |
Why?
|
| Cytoskeletal Proteins | 1 | 2007 | 1327 | 0.190 |
Why?
|
| Langerhans Cells | 1 | 2021 | 169 | 0.190 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2021 | 59 | 0.180 |
Why?
|
| Antibody-Producing Cells | 8 | 1989 | 140 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2015 | 3301 | 0.180 |
Why?
|
| Arginase | 1 | 2021 | 81 | 0.180 |
Why?
|
| Smad2 Protein | 1 | 2021 | 144 | 0.180 |
Why?
|
| Environmental Exposure | 3 | 2020 | 4543 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 3 | 2013 | 696 | 0.180 |
Why?
|
| Concanavalin A | 8 | 1988 | 190 | 0.180 |
Why?
|
| Psoriasis | 2 | 2024 | 926 | 0.180 |
Why?
|
| Smad3 Protein | 1 | 2021 | 166 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2020 | 825 | 0.180 |
Why?
|
| Synovial Membrane | 2 | 2021 | 536 | 0.180 |
Why?
|
| Fucose | 1 | 2021 | 122 | 0.180 |
Why?
|
| Microglia | 2 | 2021 | 1376 | 0.180 |
Why?
|
| Intracellular Fluid | 3 | 2011 | 201 | 0.180 |
Why?
|
| Mice, Inbred NZB | 4 | 2022 | 57 | 0.180 |
Why?
|
| Serum | 2 | 2012 | 206 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8748 | 0.170 |
Why?
|
| Lymphokines | 5 | 2000 | 924 | 0.170 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 6 | 2017 | 318 | 0.170 |
Why?
|
| Time Factors | 18 | 2020 | 40214 | 0.170 |
Why?
|
| Histone Deacetylase 1 | 2 | 2014 | 133 | 0.170 |
Why?
|
| Cell Communication | 5 | 2016 | 1660 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1966 | 0.170 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 794 | 0.170 |
Why?
|
| Hymecromone | 1 | 2019 | 9 | 0.170 |
Why?
|
| Lectins | 1 | 2022 | 490 | 0.170 |
Why?
|
| Cytoprotection | 3 | 2015 | 199 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.170 |
Why?
|
| Galactose | 1 | 2021 | 300 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 235 | 0.170 |
Why?
|
| Molecular Mimicry | 1 | 2020 | 213 | 0.170 |
Why?
|
| Ureteral Obstruction | 1 | 2021 | 293 | 0.170 |
Why?
|
| Pyrimidines | 4 | 2015 | 3046 | 0.170 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 5 | 2008 | 69 | 0.170 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 100 | 0.170 |
Why?
|
| Complement C4 | 4 | 2008 | 216 | 0.170 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.170 |
Why?
|
| Congresses as Topic | 2 | 2017 | 812 | 0.170 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 1999 | 9 | 0.160 |
Why?
|
| Lung Diseases | 2 | 2012 | 1944 | 0.160 |
Why?
|
| Disintegrins | 1 | 2019 | 27 | 0.160 |
Why?
|
| Naphthoquinones | 1 | 2019 | 60 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2007 | 433 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2014 | 4289 | 0.160 |
Why?
|
| Oxidative Stress | 3 | 2012 | 3140 | 0.160 |
Why?
|
| Germinal Center | 2 | 2020 | 380 | 0.160 |
Why?
|
| Neurotransmitter Agents | 1 | 2023 | 663 | 0.160 |
Why?
|
| Cell Polarity | 2 | 2016 | 639 | 0.160 |
Why?
|
| Clinical Medicine | 1 | 2020 | 145 | 0.160 |
Why?
|
| Heme | 1 | 2021 | 316 | 0.160 |
Why?
|
| Hydroxamic Acids | 1 | 2002 | 483 | 0.160 |
Why?
|
| Entamoebiasis | 1 | 2018 | 12 | 0.160 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1998 | 362 | 0.160 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2016 | 75 | 0.160 |
Why?
|
| Immunologic Factors | 2 | 2022 | 1594 | 0.160 |
Why?
|
| HLA-DR Antigens | 7 | 1992 | 609 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 7 | 2006 | 6119 | 0.160 |
Why?
|
| Cycloheximide | 3 | 2005 | 341 | 0.160 |
Why?
|
| Melanocytes | 1 | 2022 | 509 | 0.160 |
Why?
|
| Indicators and Reagents | 1 | 2019 | 456 | 0.160 |
Why?
|
| Heme Oxygenase-1 | 1 | 2021 | 364 | 0.150 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2017 | 169 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4414 | 0.150 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 1998 | 88 | 0.150 |
Why?
|
| Clonal Anergy | 1 | 1999 | 169 | 0.150 |
Why?
|
| Antigens, Differentiation | 4 | 2013 | 921 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 1027 | 0.150 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2019 | 250 | 0.150 |
Why?
|
| Pulmonary Circulation | 2 | 2012 | 745 | 0.150 |
Why?
|
| Enzyme Precursors | 3 | 2003 | 166 | 0.150 |
Why?
|
| Pokeweed Mitogens | 8 | 1987 | 38 | 0.150 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 335 | 0.150 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 630 | 0.150 |
Why?
|
| Rosette Formation | 8 | 1984 | 152 | 0.150 |
Why?
|
| Immunologic Capping | 3 | 1990 | 30 | 0.150 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 207 | 0.150 |
Why?
|
| Disease Progression | 5 | 2020 | 13665 | 0.140 |
Why?
|
| gamma-Linolenic Acid | 1 | 1997 | 16 | 0.140 |
Why?
|
| Immune System Diseases | 4 | 1998 | 253 | 0.140 |
Why?
|
| Infusions, Intravenous | 4 | 2018 | 2227 | 0.140 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 2 | 1995 | 69 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 553 | 0.140 |
Why?
|
| Vaccines, DNA | 2 | 2011 | 279 | 0.140 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2017 | 25 | 0.140 |
Why?
|
| Immunization | 1 | 2002 | 1218 | 0.140 |
Why?
|
| Aged, 80 and over | 12 | 2021 | 59598 | 0.140 |
Why?
|
| Antineoplastic Agents | 4 | 2018 | 13658 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 1 | 2021 | 363 | 0.140 |
Why?
|
| Agammaglobulinemia | 3 | 1989 | 173 | 0.140 |
Why?
|
| Stress, Physiological | 3 | 2004 | 1409 | 0.140 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1997 | 64 | 0.140 |
Why?
|
| Amino Acid Sequence | 9 | 2009 | 13420 | 0.140 |
Why?
|
| Oligodendroglia | 1 | 2021 | 541 | 0.140 |
Why?
|
| Myelin Sheath | 1 | 2021 | 652 | 0.140 |
Why?
|
| Cathepsin K | 1 | 2017 | 65 | 0.140 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 13000 | 0.140 |
Why?
|
| Acetyltransferases | 2 | 2012 | 231 | 0.140 |
Why?
|
| Adolescent | 26 | 2021 | 89155 | 0.140 |
Why?
|
| Antibodies, Blocking | 1 | 2017 | 250 | 0.140 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2016 | 36 | 0.140 |
Why?
|
| Acute Lung Injury | 2 | 2012 | 377 | 0.140 |
Why?
|
| Stromal Cells | 1 | 2022 | 1336 | 0.140 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 440 | 0.140 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2002 | 640 | 0.140 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1989 | 0.130 |
Why?
|
| Detergents | 3 | 2002 | 235 | 0.130 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.130 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 872 | 0.130 |
Why?
|
| Fatal Outcome | 1 | 2021 | 1836 | 0.130 |
Why?
|
| Quinolinic Acid | 1 | 1996 | 67 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 3 | 2002 | 69 | 0.130 |
Why?
|
| Wiskott-Aldrich Syndrome | 2 | 2015 | 131 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2010 | 752 | 0.130 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 1 | 1996 | 22 | 0.130 |
Why?
|
| Estrenes | 1 | 1995 | 21 | 0.130 |
Why?
|
| Neutropenia | 1 | 2021 | 892 | 0.130 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 366 | 0.130 |
Why?
|
| Myeloid Cells | 2 | 2021 | 839 | 0.130 |
Why?
|
| Rats | 13 | 2010 | 23751 | 0.130 |
Why?
|
| OX40 Ligand | 1 | 2016 | 57 | 0.130 |
Why?
|
| Cytoplasm | 5 | 2002 | 1505 | 0.130 |
Why?
|
| Protein Kinases | 2 | 2003 | 1610 | 0.130 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2008 | 87 | 0.130 |
Why?
|
| Tissue Distribution | 3 | 2007 | 2299 | 0.130 |
Why?
|
| Cathepsins | 1 | 2016 | 243 | 0.130 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2015 | 88 | 0.130 |
Why?
|
| Homeostasis | 3 | 2019 | 3348 | 0.130 |
Why?
|
| Immunologic Techniques | 3 | 2004 | 213 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2006 | 2953 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 1 | 2016 | 165 | 0.120 |
Why?
|
| Mast Cells | 2 | 2015 | 1405 | 0.120 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2016 | 197 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.120 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 863 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2008 | 1804 | 0.120 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1972 | 0.120 |
Why?
|
| Collagen | 1 | 2003 | 2641 | 0.120 |
Why?
|
| Drug Hypersensitivity | 1 | 2004 | 903 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2016 | 224 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 1752 | 0.120 |
Why?
|
| Pyrrolidinones | 1 | 1995 | 116 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2010 | 8120 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 2972 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2017 | 1441 | 0.120 |
Why?
|
| Antibodies, Protozoan | 2 | 2007 | 251 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 681 | 0.120 |
Why?
|
| Turkey | 1 | 2015 | 256 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 616 | 0.120 |
Why?
|
| DNA Primers | 3 | 2005 | 2827 | 0.120 |
Why?
|
| Cell Separation | 4 | 2012 | 1729 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 572 | 0.120 |
Why?
|
| Ceramides | 1 | 2016 | 203 | 0.120 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2014 | 25 | 0.120 |
Why?
|
| Platelet Function Tests | 1 | 2016 | 275 | 0.120 |
Why?
|
| Cell Membrane Permeability | 1 | 1996 | 571 | 0.110 |
Why?
|
| Treatment Outcome | 10 | 2022 | 65364 | 0.110 |
Why?
|
| Bleomycin | 1 | 2015 | 492 | 0.110 |
Why?
|
| Ionophores | 4 | 2011 | 108 | 0.110 |
Why?
|
| RNA Interference | 2 | 2013 | 2830 | 0.110 |
Why?
|
| Immunoconjugates | 2 | 2018 | 975 | 0.110 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2013 | 27 | 0.110 |
Why?
|
| Protein Transport | 3 | 2014 | 1951 | 0.110 |
Why?
|
| Severity of Illness Index | 10 | 2022 | 15944 | 0.110 |
Why?
|
| Swine | 3 | 2016 | 5994 | 0.110 |
Why?
|
| Trinitrobenzenes | 3 | 1988 | 45 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2014 | 125 | 0.110 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2592 | 0.110 |
Why?
|
| Thymosin | 3 | 1992 | 47 | 0.110 |
Why?
|
| Nitrobenzenes | 3 | 1988 | 64 | 0.110 |
Why?
|
| Astrocytes | 1 | 2021 | 1351 | 0.110 |
Why?
|
| Ligands | 4 | 2007 | 3284 | 0.110 |
Why?
|
| Epigenomics | 1 | 2019 | 959 | 0.110 |
Why?
|
| Tretinoin | 1 | 2016 | 524 | 0.110 |
Why?
|
| Azathioprine | 4 | 1991 | 354 | 0.110 |
Why?
|
| Histological Techniques | 1 | 2013 | 193 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 2007 | 3096 | 0.110 |
Why?
|
| Plasmids | 3 | 2012 | 2269 | 0.110 |
Why?
|
| Phytohemagglutinins | 4 | 2002 | 165 | 0.110 |
Why?
|
| Immunoglobulin E | 3 | 2015 | 1497 | 0.110 |
Why?
|
| Culture Media | 3 | 2001 | 898 | 0.110 |
Why?
|
| Platelet Aggregation | 1 | 2016 | 769 | 0.110 |
Why?
|
| Eicosanoids | 3 | 2003 | 284 | 0.110 |
Why?
|
| Th2 Cells | 2 | 2011 | 1076 | 0.110 |
Why?
|
| Natural Killer T-Cells | 1 | 2016 | 318 | 0.110 |
Why?
|
| Cloning, Molecular | 4 | 2005 | 4168 | 0.110 |
Why?
|
| Elapid Venoms | 1 | 2012 | 40 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 435 | 0.100 |
Why?
|
| Orchitis | 1 | 2012 | 36 | 0.100 |
Why?
|
| Intercellular Junctions | 1 | 2013 | 198 | 0.100 |
Why?
|
| Cell Count | 2 | 2014 | 1831 | 0.100 |
Why?
|
| Sex Factors | 3 | 2020 | 10627 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 800 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1319 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2003 | 46 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 479 | 0.100 |
Why?
|
| Macrophages | 3 | 2020 | 5799 | 0.100 |
Why?
|
| 5' Untranslated Regions | 3 | 2007 | 255 | 0.100 |
Why?
|
| Phosphoproteins | 2 | 2017 | 2450 | 0.100 |
Why?
|
| Nitriles | 1 | 2017 | 980 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4978 | 0.100 |
Why?
|
| Mutation | 6 | 2013 | 30211 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 874 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 1892 | 0.100 |
Why?
|
| Genes, Dominant | 2 | 2012 | 855 | 0.100 |
Why?
|
| Deltaretrovirus | 3 | 1986 | 162 | 0.100 |
Why?
|
| COS Cells | 2 | 2005 | 1135 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2019 | 2234 | 0.100 |
Why?
|
| Blotting, Northern | 1 | 2013 | 1550 | 0.100 |
Why?
|
| Quinolines | 1 | 2017 | 770 | 0.100 |
Why?
|
| Graft Survival | 1 | 2022 | 3887 | 0.100 |
Why?
|
| Aniline Compounds | 1 | 2017 | 1094 | 0.100 |
Why?
|
| Methylation | 2 | 2011 | 1078 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2012 | 369 | 0.100 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 286 | 0.100 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 304 | 0.090 |
Why?
|
| Dactinomycin | 2 | 2002 | 305 | 0.090 |
Why?
|
| Oncogenes | 2 | 1988 | 1232 | 0.090 |
Why?
|
| Electroporation | 2 | 2003 | 239 | 0.090 |
Why?
|
| Urinalysis | 1 | 2013 | 370 | 0.090 |
Why?
|
| Prednisone | 8 | 2008 | 1567 | 0.090 |
Why?
|
| Dipyridamole | 1 | 2011 | 143 | 0.090 |
Why?
|
| Immunoassay | 1 | 2015 | 746 | 0.090 |
Why?
|
| Osteopontin | 1 | 2013 | 306 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2012 | 163 | 0.090 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2011 | 97 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2011 | 235 | 0.090 |
Why?
|
| Erythrocyte Deformability | 1 | 2011 | 55 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 1996 | 761 | 0.090 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2002 | 103 | 0.090 |
Why?
|
| Computational Biology | 2 | 2014 | 3568 | 0.090 |
Why?
|
| Cecum | 1 | 2011 | 231 | 0.090 |
Why?
|
| Sus scrofa | 1 | 2012 | 430 | 0.090 |
Why?
|
| Genetic Variation | 3 | 2020 | 6611 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2008 | 91 | 0.090 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2018 | 2442 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2004 | 507 | 0.090 |
Why?
|
| Estradiol | 1 | 1997 | 1951 | 0.090 |
Why?
|
| Injury Severity Score | 1 | 2014 | 1049 | 0.090 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2011 | 213 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 1998 | 1072 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2634 | 0.090 |
Why?
|
| Acidosis | 1 | 2012 | 271 | 0.090 |
Why?
|
| Models, Biological | 5 | 2012 | 9493 | 0.090 |
Why?
|
| Viral Proteins | 2 | 2016 | 1802 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 2884 | 0.090 |
Why?
|
| Histone Acetyltransferases | 2 | 2003 | 335 | 0.090 |
Why?
|
| Imidazoles | 1 | 1996 | 1168 | 0.090 |
Why?
|
| Platelet Count | 2 | 2012 | 787 | 0.090 |
Why?
|
| Bucladesine | 2 | 2001 | 118 | 0.080 |
Why?
|
| HSP72 Heat-Shock Proteins | 2 | 2000 | 40 | 0.080 |
Why?
|
| Prospective Studies | 5 | 2020 | 54924 | 0.080 |
Why?
|
| Receptors, Transferrin | 2 | 1990 | 300 | 0.080 |
Why?
|
| Herpesvirus 2, Saimiriine | 2 | 2006 | 61 | 0.080 |
Why?
|
| IgG Deficiency | 1 | 1989 | 28 | 0.080 |
Why?
|
| Annexin A4 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Gene Deletion | 2 | 2015 | 2673 | 0.080 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2010 | 175 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1110 | 0.080 |
Why?
|
| Infant, Newborn | 7 | 2020 | 26420 | 0.080 |
Why?
|
| Isoantigens | 5 | 1990 | 562 | 0.080 |
Why?
|
| Protein Precursors | 3 | 1992 | 1134 | 0.080 |
Why?
|
| Remission Induction | 1 | 2015 | 2409 | 0.080 |
Why?
|
| Endotoxins | 1 | 2012 | 519 | 0.080 |
Why?
|
| Laparotomy | 1 | 2012 | 459 | 0.080 |
Why?
|
| Epidermis | 3 | 1998 | 539 | 0.080 |
Why?
|
| Glycosylation | 2 | 2003 | 1100 | 0.080 |
Why?
|
| Erythrocyte Membrane | 1 | 2011 | 438 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2011 | 348 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2011 | 349 | 0.080 |
Why?
|
| Receptor Aggregation | 2 | 2004 | 72 | 0.080 |
Why?
|
| Complement C3b Inactivator Proteins | 2 | 1986 | 13 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 3435 | 0.080 |
Why?
|
| Chelating Agents | 2 | 2002 | 385 | 0.080 |
Why?
|
| Cytochalasin D | 1 | 2008 | 91 | 0.080 |
Why?
|
| Isoquinolines | 2 | 2002 | 354 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 699 | 0.080 |
Why?
|
| Ubiquitination | 1 | 2013 | 1008 | 0.080 |
Why?
|
| Ascites | 1 | 1991 | 338 | 0.080 |
Why?
|
| Cell Degranulation | 1 | 2010 | 276 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6071 | 0.080 |
Why?
|
| Cell Cycle | 4 | 2000 | 2932 | 0.080 |
Why?
|
| Cholesterol | 1 | 2018 | 2914 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2010 | 223 | 0.080 |
Why?
|
| Phosphotyrosine | 2 | 2001 | 458 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2009 | 219 | 0.080 |
Why?
|
| Peritonitis | 1 | 1991 | 368 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3447 | 0.080 |
Why?
|
| Cryoglobulins | 1 | 2008 | 58 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2006 | 2094 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 1405 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2020 | 2574 | 0.080 |
Why?
|
| Immunoglobulin A | 2 | 2011 | 991 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2010 | 348 | 0.080 |
Why?
|
| Cell Aggregation | 1 | 2008 | 238 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2002 | 1683 | 0.080 |
Why?
|
| Galactosidases | 1 | 1987 | 55 | 0.080 |
Why?
|
| Complement Pathway, Classical | 1 | 1988 | 91 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 1731 | 0.070 |
Why?
|
| Graft vs Host Disease | 3 | 2017 | 3049 | 0.070 |
Why?
|
| DNA Damage | 1 | 2018 | 2470 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 9666 | 0.070 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12075 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2013 | 540 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 588 | 0.070 |
Why?
|
| Exons | 3 | 2018 | 2393 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2020 | 2029 | 0.070 |
Why?
|
| Herpesviridae Infections | 2 | 1986 | 269 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1367 | 0.070 |
Why?
|
| Uveitis | 1 | 2011 | 398 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 505 | 0.070 |
Why?
|
| Synapses | 1 | 2017 | 1765 | 0.070 |
Why?
|
| Nucleosomes | 1 | 2011 | 492 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 662 | 0.070 |
Why?
|
| Double-Blind Method | 5 | 2022 | 12464 | 0.070 |
Why?
|
| Sporozoites | 1 | 2007 | 83 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2006 | 1883 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 4 | 1997 | 1134 | 0.070 |
Why?
|
| Survival Rate | 3 | 2012 | 12828 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 1335 | 0.070 |
Why?
|
| Immune Sera | 2 | 2004 | 605 | 0.070 |
Why?
|
| Lymphocyte Depletion | 1 | 2009 | 605 | 0.070 |
Why?
|
| Genes, MHC Class II | 3 | 2012 | 433 | 0.070 |
Why?
|
| Brain Diseases | 1 | 1996 | 1554 | 0.070 |
Why?
|
| Inositol Phosphates | 2 | 1997 | 175 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1986 | 2204 | 0.070 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1989 | 393 | 0.070 |
Why?
|
| Receptors, Estrogen | 3 | 2000 | 2253 | 0.070 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2007 | 99 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 1150 | 0.070 |
Why?
|
| Cross-Linking Reagents | 2 | 2006 | 693 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2010 | 1151 | 0.070 |
Why?
|
| Risk Factors | 7 | 2020 | 74936 | 0.070 |
Why?
|
| beta-Galactosidase | 1 | 1987 | 574 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 729 | 0.070 |
Why?
|
| Binding Sites, Antibody | 2 | 2001 | 340 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2017 | 1251 | 0.070 |
Why?
|
| Uridine | 1 | 2006 | 135 | 0.070 |
Why?
|
| Cell Survival | 2 | 2014 | 5772 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2016 | 2906 | 0.070 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2006 | 220 | 0.070 |
Why?
|
| snRNP Core Proteins | 1 | 2006 | 21 | 0.070 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 930 | 0.070 |
Why?
|
| Genes, RAG-1 | 1 | 2006 | 68 | 0.070 |
Why?
|
| Hemodynamics | 3 | 2016 | 4194 | 0.070 |
Why?
|
| Malaria Vaccines | 1 | 2007 | 165 | 0.060 |
Why?
|
| Stomach Neoplasms | 2 | 2006 | 1481 | 0.060 |
Why?
|
| Binding, Competitive | 3 | 2003 | 1142 | 0.060 |
Why?
|
| Viral Matrix Proteins | 2 | 2013 | 193 | 0.060 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2005 | 74 | 0.060 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2005 | 760 | 0.060 |
Why?
|
| Terpenes | 2 | 1995 | 102 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3329 | 0.060 |
Why?
|
| Lymphocyte Cooperation | 3 | 1992 | 112 | 0.060 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2004 | 28 | 0.060 |
Why?
|
| Hindlimb | 1 | 2007 | 516 | 0.060 |
Why?
|
| Peroxidase | 2 | 2009 | 610 | 0.060 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 1985 | 61 | 0.060 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2004 | 62 | 0.060 |
Why?
|
| Densitometry | 1 | 2005 | 151 | 0.060 |
Why?
|
| Muromonab-CD3 | 2 | 2002 | 104 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 6843 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 9016 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2002 | 1124 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6517 | 0.060 |
Why?
|
| Cell Culture Techniques | 3 | 2016 | 1667 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 843 | 0.060 |
Why?
|
| Clone Cells | 4 | 2001 | 1669 | 0.060 |
Why?
|
| Serine | 3 | 2004 | 831 | 0.060 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 2004 | 16 | 0.060 |
Why?
|
| Interleukin-1 | 3 | 2024 | 1252 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1656 | 0.060 |
Why?
|
| Peer Group | 1 | 2010 | 702 | 0.060 |
Why?
|
| Sirolimus | 2 | 2022 | 1538 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 4 | 1990 | 897 | 0.060 |
Why?
|
| Immune Complex Diseases | 1 | 1984 | 50 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2007 | 660 | 0.060 |
Why?
|
| Communicable Diseases | 2 | 2005 | 874 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 2020 | 2219 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2012 | 8540 | 0.060 |
Why?
|
| Myenteric Plexus | 1 | 2003 | 49 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2010 | 2602 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 279 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2014 | 2981 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3701 | 0.050 |
Why?
|
| Feces | 2 | 2022 | 1510 | 0.050 |
Why?
|
| Gangliosides | 1 | 2004 | 132 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 1983 | 39 | 0.050 |
Why?
|
| Allopurinol | 2 | 2002 | 202 | 0.050 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 2003 | 30 | 0.050 |
Why?
|
| Reference Values | 4 | 1997 | 4938 | 0.050 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2003 | 18 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2024 | 206 | 0.050 |
Why?
|
| Tumor Escape | 1 | 2006 | 372 | 0.050 |
Why?
|
| Anemia, Aplastic | 2 | 1985 | 231 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 958 | 0.050 |
Why?
|
| Prevalence | 2 | 2015 | 15867 | 0.050 |
Why?
|
| Chemical Precipitation | 1 | 2003 | 175 | 0.050 |
Why?
|
| Child | 14 | 2012 | 80906 | 0.050 |
Why?
|
| Lod Score | 1 | 2004 | 600 | 0.050 |
Why?
|
| Calcimycin | 2 | 2001 | 214 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2002 | 76 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1120 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2024 | 165 | 0.050 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2003 | 167 | 0.050 |
Why?
|
| Neutrophil Activation | 1 | 2003 | 180 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2000 | 707 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 816 | 0.050 |
Why?
|
| Galectin 1 | 1 | 2023 | 128 | 0.050 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2003 | 195 | 0.050 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 1982 | 306 | 0.050 |
Why?
|
| Neurosecretory Systems | 1 | 2004 | 223 | 0.050 |
Why?
|
| Integrins | 1 | 2007 | 842 | 0.050 |
Why?
|
| Sunlight | 1 | 2004 | 337 | 0.050 |
Why?
|
| Venules | 1 | 2022 | 161 | 0.050 |
Why?
|
| TATA-Box Binding Protein | 1 | 2002 | 99 | 0.050 |
Why?
|
| Cisplatin | 2 | 1996 | 1658 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 1492 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2004 | 619 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2000 | 21206 | 0.050 |
Why?
|
| Carbohydrate Conformation | 1 | 2002 | 206 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2003 | 1435 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 2011 | 0.050 |
Why?
|
| Malaria, Falciparum | 1 | 2010 | 1077 | 0.050 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2021 | 48 | 0.050 |
Why?
|
| Hydrocortisone | 4 | 2022 | 1840 | 0.050 |
Why?
|
| Heparin | 1 | 2009 | 1636 | 0.050 |
Why?
|
| Protein Engineering | 1 | 2005 | 555 | 0.050 |
Why?
|
| Adenosine | 1 | 2006 | 820 | 0.050 |
Why?
|
| Maleimides | 1 | 2002 | 112 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 26375 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2022 | 703 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2022 | 100 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 1133 | 0.050 |
Why?
|
| Cell Fractionation | 1 | 2002 | 247 | 0.050 |
Why?
|
| src-Family Kinases | 2 | 2017 | 539 | 0.050 |
Why?
|
| PAX7 Transcription Factor | 1 | 2021 | 55 | 0.050 |
Why?
|
| Ferrochelatase | 1 | 2021 | 47 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 188 | 0.050 |
Why?
|
| Acetophenones | 1 | 2001 | 52 | 0.050 |
Why?
|
| Guanidines | 1 | 2002 | 194 | 0.050 |
Why?
|
| Benzopyrans | 1 | 2001 | 63 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2002 | 310 | 0.050 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2021 | 139 | 0.050 |
Why?
|
| Actinomyces | 1 | 2020 | 41 | 0.050 |
Why?
|
| K562 Cells | 2 | 2013 | 644 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 213 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 1985 | 839 | 0.050 |
Why?
|
| Biological Transport | 3 | 2000 | 2085 | 0.050 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 2021 | 64 | 0.050 |
Why?
|
| Lupus Vulgaris | 1 | 2000 | 10 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2002 | 2271 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 12536 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2021 | 143 | 0.040 |
Why?
|
| Clostridium | 1 | 2020 | 100 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2003 | 577 | 0.040 |
Why?
|
| Acetylglucosamine | 1 | 2002 | 189 | 0.040 |
Why?
|
| Acetylcysteine | 1 | 2002 | 262 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 210 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2024 | 594 | 0.040 |
Why?
|
| Actinobacteria | 1 | 2020 | 62 | 0.040 |
Why?
|
| Chemokines, CC | 1 | 2021 | 286 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 2010 | 1741 | 0.040 |
Why?
|
| Antibody Affinity | 2 | 1992 | 252 | 0.040 |
Why?
|
| Nanomedicine | 1 | 2023 | 292 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2005 | 667 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 13489 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2021 | 686 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 414 | 0.040 |
Why?
|
| Staphylococcus aureus | 2 | 1990 | 1430 | 0.040 |
Why?
|
| Skin Pigmentation | 1 | 2022 | 280 | 0.040 |
Why?
|
| Uremia | 1 | 1981 | 202 | 0.040 |
Why?
|
| Cyclophosphamide | 4 | 1989 | 2227 | 0.040 |
Why?
|
| Chlorpromazine | 1 | 1980 | 111 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2005 | 935 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2020 | 220 | 0.040 |
Why?
|
| Peptides, Cyclic | 1 | 2002 | 391 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 1753 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 414 | 0.040 |
Why?
|
| Fluorescamine | 1 | 1979 | 4 | 0.040 |
Why?
|
| Phenylmercury Compounds | 1 | 1979 | 3 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 1986 | 1484 | 0.040 |
Why?
|
| 4-Chloromercuribenzenesulfonate | 1 | 1979 | 7 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 542 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 840 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit | 3 | 2004 | 6 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 3 | 2004 | 10 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2020 | 250 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2000 | 301 | 0.040 |
Why?
|
| Alleles | 3 | 2018 | 6894 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 1985 | 535 | 0.040 |
Why?
|
| Dysentery, Amebic | 1 | 2018 | 6 | 0.040 |
Why?
|
| Janus Kinase 3 | 1 | 2019 | 75 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2022 | 555 | 0.040 |
Why?
|
| Haplotypes | 2 | 2018 | 2722 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 154 | 0.040 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 375 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2023 | 1837 | 0.040 |
Why?
|
| Granulocytes | 1 | 2001 | 551 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12795 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2003 | 1750 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 17128 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 1998 | 176 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2004 | 1652 | 0.040 |
Why?
|
| Antigens | 2 | 1998 | 1442 | 0.040 |
Why?
|
| Entamoeba histolytica | 1 | 2018 | 28 | 0.040 |
Why?
|
| Normal Distribution | 1 | 1999 | 272 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 6371 | 0.040 |
Why?
|
| Spiro Compounds | 1 | 1979 | 69 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2002 | 772 | 0.040 |
Why?
|
| Autoradiography | 1 | 1999 | 727 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 664 | 0.040 |
Why?
|
| Antibody Specificity | 4 | 1989 | 1065 | 0.040 |
Why?
|
| C-Reactive Protein | 2 | 2009 | 3858 | 0.040 |
Why?
|
| Cytotoxicity Tests, Immunologic | 3 | 1984 | 317 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2021 | 41749 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2020 | 300 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2020 | 267 | 0.040 |
Why?
|
| Mouth | 1 | 2020 | 383 | 0.040 |
Why?
|
| Sodium | 1 | 2003 | 1597 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 1985 | 1319 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2766 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2004 | 1308 | 0.040 |
Why?
|
| Calcineurin | 1 | 1998 | 235 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2004 | 2201 | 0.040 |
Why?
|
| Cullin Proteins | 1 | 2018 | 180 | 0.040 |
Why?
|
| Child, Preschool | 6 | 2018 | 42665 | 0.040 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 2336 | 0.040 |
Why?
|
| Epitopes | 5 | 1990 | 2526 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 3 | 1993 | 283 | 0.040 |
Why?
|
| Phosphates | 1 | 1981 | 765 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2342 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 792 | 0.040 |
Why?
|
| Selectins | 1 | 1997 | 101 | 0.030 |
Why?
|
| Metagenomics | 1 | 2020 | 474 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1981 | 553 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 21532 | 0.030 |
Why?
|
| Leukotriene B4 | 3 | 2005 | 281 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 1207 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2017 | 364 | 0.030 |
Why?
|
| Thyrotoxicosis | 1 | 1997 | 85 | 0.030 |
Why?
|
| Boston | 1 | 2010 | 9368 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 661 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2017 | 145 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1136 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2001 | 1494 | 0.030 |
Why?
|
| Miconazole | 1 | 1996 | 9 | 0.030 |
Why?
|
| Econazole | 1 | 1996 | 4 | 0.030 |
Why?
|
| Cell-Free System | 2 | 1988 | 339 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 8052 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2065 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2017 | 164 | 0.030 |
Why?
|
| Lidocaine | 1 | 1980 | 546 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2017 | 190 | 0.030 |
Why?
|
| Proteins | 2 | 2004 | 6009 | 0.030 |
Why?
|
| Poly I-C | 1 | 2016 | 111 | 0.030 |
Why?
|
| Pancreas | 1 | 2023 | 1700 | 0.030 |
Why?
|
| Cattle | 2 | 2000 | 3819 | 0.030 |
Why?
|
| Down Syndrome | 1 | 1985 | 919 | 0.030 |
Why?
|
| Clotrimazole | 1 | 1996 | 76 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 1997 | 216 | 0.030 |
Why?
|
| Leukocyte Count | 4 | 1989 | 1609 | 0.030 |
Why?
|
| Cyclins | 1 | 2018 | 605 | 0.030 |
Why?
|
| Steroids | 1 | 2001 | 938 | 0.030 |
Why?
|
| RNA | 4 | 2011 | 2718 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2019 | 559 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1996 | 425 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2018 | 577 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2002 | 3956 | 0.030 |
Why?
|
| Mitogens | 3 | 1994 | 229 | 0.030 |
Why?
|
| Graves Disease | 1 | 1997 | 239 | 0.030 |
Why?
|
| B-Cell Activating Factor | 1 | 2016 | 116 | 0.030 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1995 | 122 | 0.030 |
Why?
|
| Tetanus Toxoid | 1 | 1996 | 188 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1901 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2021 | 1165 | 0.030 |
Why?
|
| Prednisolone | 1 | 1996 | 326 | 0.030 |
Why?
|
| Antimalarials | 1 | 2002 | 909 | 0.030 |
Why?
|
| Complement Factor H | 2 | 1986 | 110 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 4618 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2000 | 1104 | 0.030 |
Why?
|
| Infant | 4 | 2018 | 36534 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 7470 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2023 | 3216 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2415 | 0.030 |
Why?
|
| Femoral Neck Fractures | 1 | 2016 | 143 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2023 | 1086 | 0.030 |
Why?
|
| Uric Acid | 1 | 1981 | 805 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2020 | 951 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 1999 | 762 | 0.030 |
Why?
|
| Soft Tissue Injuries | 1 | 2016 | 173 | 0.030 |
Why?
|
| Education, Medical | 1 | 2006 | 1742 | 0.030 |
Why?
|
| Angioedema | 2 | 1986 | 184 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 3841 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2010 | 3463 | 0.030 |
Why?
|
| Capillaries | 1 | 2017 | 756 | 0.030 |
Why?
|
| Tryptophan | 1 | 1996 | 482 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1998 | 2487 | 0.030 |
Why?
|
| Indoles | 1 | 2002 | 1835 | 0.030 |
Why?
|
| Adrenal Glands | 2 | 1987 | 557 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3433 | 0.030 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1981 | 1374 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 2107 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1986 | 636 | 0.030 |
Why?
|
| Hematologic Neoplasms | 1 | 2005 | 1907 | 0.030 |
Why?
|
| Environment | 1 | 2000 | 1121 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 1838 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2002 | 1388 | 0.030 |
Why?
|
| Sepsis | 1 | 2007 | 2608 | 0.030 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 1993 | 110 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2013 | 56 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1995 | 351 | 0.030 |
Why?
|
| Intradermal Tests | 1 | 2012 | 43 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 1994 | 236 | 0.030 |
Why?
|
| Vasculitis | 1 | 1997 | 525 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 1999 | 1172 | 0.030 |
Why?
|
| Prognosis | 2 | 2020 | 29979 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2013 | 99 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 839 | 0.030 |
Why?
|
| Haptens | 1 | 2012 | 163 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2005 | 4492 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1993 | 289 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1993 | 419 | 0.020 |
Why?
|
| Galactosylceramides | 1 | 2012 | 90 | 0.020 |
Why?
|
| Lymphoma | 1 | 1981 | 1897 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2000 | 1422 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2012 | 624 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2022 | 4176 | 0.020 |
Why?
|
| Myasthenia Gravis | 1 | 1994 | 214 | 0.020 |
Why?
|
| Diarrhea | 1 | 2018 | 1320 | 0.020 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2011 | 69 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2016 | 3074 | 0.020 |
Why?
|
| Demography | 1 | 1996 | 1641 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 1990 | 171 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1990 | 73 | 0.020 |
Why?
|
| Interphase | 3 | 2003 | 226 | 0.020 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1990 | 62 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 81746 | 0.020 |
Why?
|
| Neurons | 1 | 2010 | 9518 | 0.020 |
Why?
|
| Spectrin | 1 | 2011 | 176 | 0.020 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1990 | 42 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1993 | 647 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14718 | 0.020 |
Why?
|
| Merozoites | 1 | 2010 | 60 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2002 | 2540 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2012 | 426 | 0.020 |
Why?
|
| Plant Oils | 1 | 1991 | 199 | 0.020 |
Why?
|
| Antigens, CD19 | 1 | 2013 | 446 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3443 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2945 | 0.020 |
Why?
|
| Testis | 1 | 2012 | 783 | 0.020 |
Why?
|
| Cross Reactions | 2 | 1990 | 828 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1862 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 452 | 0.020 |
Why?
|
| Virus Internalization | 1 | 2013 | 504 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 610 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1991 | 6314 | 0.020 |
Why?
|
| Immunoglobulin D | 1 | 1988 | 55 | 0.020 |
Why?
|
| Blood Donors | 1 | 2011 | 343 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 2009 | 134 | 0.020 |
Why?
|
| Structure-Activity Relationship | 2 | 2002 | 3055 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3620 | 0.020 |
Why?
|
| Thymidine | 2 | 1986 | 297 | 0.020 |
Why?
|
| Myositis | 2 | 1981 | 269 | 0.020 |
Why?
|
| Cell Division | 4 | 2000 | 4473 | 0.020 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 381 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 1988 | 73 | 0.020 |
Why?
|
| Brain | 3 | 2012 | 27366 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1998 | 2650 | 0.020 |
Why?
|
| Peptides | 1 | 2000 | 4354 | 0.020 |
Why?
|
| Pedigree | 1 | 1996 | 4539 | 0.020 |
Why?
|
| Serologic Tests | 1 | 1990 | 382 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 342 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2010 | 928 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2012 | 966 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 1305 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 599 | 0.020 |
Why?
|
| Leukemia | 2 | 1986 | 1519 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 1988 | 185 | 0.020 |
Why?
|
| Fishes | 1 | 1991 | 606 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 1992 | 1363 | 0.020 |
Why?
|
| Administration, Oral | 3 | 2009 | 4030 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1377 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 1990 | 998 | 0.020 |
Why?
|
| Dendrites | 1 | 2010 | 472 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 30260 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1495 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2007 | 363 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3912 | 0.020 |
Why?
|
| Brucella abortus | 1 | 1986 | 14 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 135 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 687 | 0.020 |
Why?
|
| Temperature | 1 | 2013 | 2234 | 0.020 |
Why?
|
| Mycophenolic Acid | 1 | 2008 | 348 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 4771 | 0.020 |
Why?
|
| Paracoccidioidomycosis | 1 | 1985 | 10 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3948 | 0.020 |
Why?
|
| Oncogene Protein v-cbl | 1 | 2005 | 11 | 0.020 |
Why?
|
| Complement C1q | 1 | 1986 | 93 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1739 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2009 | 9384 | 0.020 |
Why?
|
| Half-Life | 1 | 1986 | 651 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1990 | 1088 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2005 | 120 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1993 | 1207 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1512 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2004 | 24 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 1990 | 1141 | 0.010 |
Why?
|
| Hippocampus | 1 | 2017 | 3786 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2131 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14783 | 0.010 |
Why?
|
| Synovitis | 1 | 1985 | 217 | 0.010 |
Why?
|
| Zymosan | 1 | 1984 | 134 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2012 | 1536 | 0.010 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2006 | 435 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2003 | 260 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1986 | 748 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 2655 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1986 | 557 | 0.010 |
Why?
|
| Leukocytes | 2 | 1982 | 2035 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 1996 | 7140 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1986 | 1698 | 0.010 |
Why?
|
| CHO Cells | 1 | 2005 | 1379 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1985 | 423 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1985 | 635 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 244 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 1984 | 490 | 0.010 |
Why?
|
| Graft vs Host Reaction | 1 | 1982 | 99 | 0.010 |
Why?
|
| Necrosis | 1 | 1986 | 1616 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 2423 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2000 | 5717 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 2002 | 243 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3780 | 0.010 |
Why?
|
| Receptors, Concanavalin A | 1 | 1980 | 11 | 0.010 |
Why?
|
| Gold | 1 | 1985 | 488 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 1986 | 1264 | 0.010 |
Why?
|
| Dermatomyositis | 1 | 1984 | 259 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6339 | 0.010 |
Why?
|
| Muscle Spasticity | 1 | 1981 | 159 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1996 | 6311 | 0.010 |
Why?
|
| Permeability | 1 | 2002 | 725 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 1982 | 476 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2002 | 628 | 0.010 |
Why?
|
| Trypan Blue | 1 | 1999 | 20 | 0.010 |
Why?
|
| Affect | 1 | 1988 | 1495 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1979 | 53 | 0.010 |
Why?
|
| Linoleic Acids | 1 | 1979 | 39 | 0.010 |
Why?
|
| Phagocytes | 1 | 1981 | 294 | 0.010 |
Why?
|
| Androgens | 1 | 1987 | 1281 | 0.010 |
Why?
|
| Muscles | 2 | 1981 | 1582 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1981 | 684 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1982 | 693 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 39345 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2003 | 827 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1980 | 157 | 0.010 |
Why?
|
| Chlorides | 1 | 2002 | 666 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2863 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 506 | 0.010 |
Why?
|
| Enteric Nervous System | 1 | 2002 | 213 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1986 | 2201 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 1986 | 1341 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2000 | 3402 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1981 | 338 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1996 | 20757 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 2004 | 707 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2001 | 706 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3269 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 2002 | 414 | 0.010 |
Why?
|
| Acute Disease | 3 | 2002 | 7241 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2731 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2000 | 329 | 0.010 |
Why?
|
| Cholestyramine Resin | 1 | 1997 | 25 | 0.010 |
Why?
|
| Methimazole | 1 | 1997 | 41 | 0.010 |
Why?
|
| Genome | 1 | 2006 | 1754 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1980 | 309 | 0.010 |
Why?
|
| United States | 1 | 2006 | 73027 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3904 | 0.010 |
Why?
|
| Antithyroid Agents | 1 | 1997 | 72 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1997 | 100 | 0.010 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2000 | 639 | 0.010 |
Why?
|
| Uveitis, Anterior | 1 | 1977 | 103 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2846 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 13042 | 0.010 |
Why?
|
| Potassium | 1 | 1981 | 1314 | 0.010 |
Why?
|
| Mice, Inbred Strains | 2 | 1991 | 1765 | 0.010 |
Why?
|
| Anxiety Disorders | 1 | 1988 | 2748 | 0.010 |
Why?
|
| Atrophy | 1 | 1981 | 1646 | 0.010 |
Why?
|
| Sheep | 1 | 1979 | 1451 | 0.010 |
Why?
|
| Staurosporine | 1 | 1997 | 241 | 0.010 |
Why?
|
| Thyrotropin | 1 | 1999 | 835 | 0.010 |
Why?
|
| Placenta | 1 | 1985 | 1725 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1987 | 4215 | 0.010 |
Why?
|
| Drug Administration Schedule | 3 | 1988 | 4857 | 0.010 |
Why?
|
| E-Selectin | 1 | 1997 | 577 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1988 | 3721 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2000 | 2120 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 1987 | 619 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5813 | 0.010 |
Why?
|
| Synovial Fluid | 1 | 1995 | 393 | 0.010 |
Why?
|
| Diet | 1 | 1991 | 8087 | 0.010 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1992 | 40 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1977 | 1334 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1991 | 158 | 0.010 |
Why?
|
| HLA-B7 Antigen | 1 | 1990 | 48 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 1985 | 3986 | 0.010 |
Why?
|
| gamma-Globulins | 1 | 1990 | 119 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 1990 | 46 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 4351 | 0.010 |
Why?
|
| Immunochemistry | 1 | 1990 | 116 | 0.010 |
Why?
|
| Cations | 1 | 1989 | 240 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1990 | 642 | 0.000 |
Why?
|
| Pseudotumor Cerebri | 1 | 1990 | 107 | 0.000 |
Why?
|
| Selection, Genetic | 1 | 1993 | 877 | 0.000 |
Why?
|
| Interleukin-3 | 1 | 1989 | 425 | 0.000 |
Why?
|
| Vincristine | 1 | 1990 | 1040 | 0.000 |
Why?
|
| Hydroxyurea | 1 | 1988 | 284 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 3409 | 0.000 |
Why?
|
| Receptors, Dopamine | 1 | 1988 | 293 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1985 | 5887 | 0.000 |
Why?
|
| Complement C3c | 1 | 1985 | 7 | 0.000 |
Why?
|
| Haploidy | 1 | 1986 | 127 | 0.000 |
Why?
|
| Interferon Inducers | 1 | 1985 | 24 | 0.000 |
Why?
|
| Thyroiditis | 1 | 1986 | 86 | 0.000 |
Why?
|
| Benz(a)Anthracenes | 1 | 1985 | 11 | 0.000 |
Why?
|
| Methylcholanthrene | 1 | 1985 | 30 | 0.000 |
Why?
|
| Prostaglandins | 1 | 1986 | 398 | 0.000 |
Why?
|
| Microsomes, Liver | 1 | 1985 | 174 | 0.000 |
Why?
|
| Microsomes | 1 | 1985 | 252 | 0.000 |
Why?
|
| Insulin | 1 | 1999 | 6606 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1985 | 455 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 863 | 0.000 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1985 | 246 | 0.000 |
Why?
|
| Depression | 1 | 2004 | 8231 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1997 | 10396 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1982 | 526 | 0.000 |
Why?
|
| Weight Gain | 1 | 1990 | 2359 | 0.000 |
Why?
|
| Glycerophosphates | 1 | 1979 | 51 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1979 | 311 | 0.000 |
Why?
|
| Arthritis, Reactive | 1 | 1977 | 20 | 0.000 |
Why?
|
| Recurrence | 1 | 1990 | 8507 | 0.000 |
Why?
|
| Eosinophilia | 1 | 1982 | 554 | 0.000 |
Why?
|
| Greece | 1 | 1977 | 340 | 0.000 |
Why?
|
| Socioeconomic Factors | 1 | 1991 | 7851 | 0.000 |
Why?
|
| Biopsy | 1 | 1988 | 6786 | 0.000 |
Why?
|
| Pseudomonas Infections | 1 | 1980 | 623 | 0.000 |
Why?
|
| Stem Cells | 1 | 1988 | 3537 | 0.000 |
Why?
|
| Bone Marrow Transplantation | 1 | 1982 | 2710 | 0.000 |
Why?
|
| Cognition Disorders | 1 | 1988 | 3977 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1980 | 1361 | 0.000 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1980 | 1276 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1979 | 1811 | 0.000 |
Why?
|
| Hypertension | 1 | 1990 | 8616 | 0.000 |
Why?
|